Graft versus host diseases: new versions of old problems?
作者信息
Denman A M
出版信息
Br Med J (Clin Res Ed). 1985 Mar 2;290(6469):658-60. doi: 10.1136/bmj.290.6469.658.
Abstract
摘要
相似文献
1
Graft versus host diseases: new versions of old problems?
Br Med J (Clin Res Ed). 1985 Mar 2;290(6469):658-60. doi: 10.1136/bmj.290.6469.658.
2
Graft-versus-host disease.
Immunol Rev. 1985 Dec;88:193-214. doi: 10.1111/j.1600-065x.1985.tb01159.x.
3
Role of immunosuppressive drugs for prevention of graft-v-host disease after human HLA matched bone marrow transplantation.
Transplant Proc. 1987 Dec;19(6 Suppl 7):61-5.
4
Prevention and treatment of acute graft-versus-host disease.
Semin Hematol. 1984 Apr;21(2):91-100.
5
Bone marrow transplantation with ciclosporin.
Prog Allergy. 1986;38:404-31.
6
Cyclosporine-induced syngeneic graft-versus-host disease: assessment of T cell differentiation.
Transplant Proc. 1987 Feb;19(1 Pt 3):2683-6.
7
Results of four different protocols for prophylaxis against graft-versus-host disease.
Transplant Proc. 1989 Feb;21(1 Pt 3):3008-10.
8
[Prevention of graft versus host disease by in vitro immunodepletion of the graft].
Nouv Rev Fr Hematol (1978). 1985;27(6):349-50.
9
[Cyclosporin in allogeneic bone marrow transplantation].
Internist (Berl). 1985 Sep;26(9):569-74.
引用本文的文献
1
Modulation of in vitro myelopoiesis by alloreactive T cell clones.
Blut. 1986 May;52(5):305-15. doi: 10.1007/BF00320794.
2
Graft versus leukemia in bone marrow transplantation.
Blut. 1988 Aug;57(2):57-63. doi: 10.1007/BF00319727.
本文引用的文献
1
Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: a randomized trial comparing antithymocyte globulin and corticosteroids.
Am J Hematol. 1981;11(1):1-8. doi: 10.1002/ajh.2830110102.
2
Acute and chronic graft versus host disease: histopathological evidence for two distinct pathogenetic mechanisms.
Hum Pathol. 1984 Mar;15(3):202-5. doi: 10.1016/s0046-8177(84)80180-x.
3
4
T lymphocyte reconstitution in long-term survivors after allogeneic and autologous marrow transplantation.
Transplantation. 1984 Jun;37(6):552-6. doi: 10.1097/00007890-198406000-00005.
5
Cyclosporine does not prevent in vivo expression of T cell activation antigens following allogeneic bone marrow transplantation.
Transplantation. 1984 Feb;37(2):219-20.
6
Recovery of in vivo cellular immunity after human marrow grafting. Influence of time postgrafting and acute graft-versus-host disease.
Transplantation. 1984 Feb;37(2):145-50. doi: 10.1097/00007890-198402000-00006.
7
Keratinocytes synthesize Ia antigen in acute cutaneous graft-vs-host disease.
J Immunol. 1983 Dec;131(6):2741-5.
8
Dermatological aspects of the use of Cyclosporin A for prophylaxis of graft-versus-host disease.
Br J Dermatol. 1984 Apr;110(4):469-74. doi: 10.1111/j.1365-2133.1984.tb04662.x.
9
10
Study of Langerhans cells after allogeneic bone marrow transplantation.
Blood. 1984 Apr;63(4):807-11.
Zotero 插件